Microbiologic epidemiology depending on time to occurrence of prosthetic joint infection: a prospective cohort study

Autor: Ferry, T., Valour, F., Perpoint, T., Boibieux, A., Biron, F., Miailhes, P., Ader, F., Becker, A., Roux, S., Triffault-Fillit, C., Daoud, F., Lippman, J., Braun, E., Chidiac, C., Gillet, Y., Hees, L., Lustig, S., Servien, E., Herry, Y., Gaillard, R., Schneider, A., Fessy, M.-H., Viste, A., Chaudier, P., Desmarchelier, R., Mouton, T., Courtin, C., Louboutin, L., Martres, S., Trouillet, F., Barrey, C., Signorelli, F., Jouanneau, E., Jacquesson, T., Mojallal, A., Boucher, F., Shipkov, H., Château, J., Aubrun, F., Bobineau, I., Macabéo, C., Laurent, F., Vandenesch, F., Rasigade, J.-P., Dupieux, C., Craighero, F., Boussel, L., Pialat, J.-B., Morelec, I., Janier, M., Giammarile, F., Tod, M., Gagnieu, M.-C., Goutelle, S., Gerbier-Colomban, S., Benet, T., Mabrut, E., Pradat, P., Conrad, A., Fessy, M.H.

Publikováno v: In Clinical Microbiology and Infection March 2019 25(3):353-358

Antiviral Res

Autor: Venisse, N., Peytavin, G., Bouchet, Stéphane, Gagnieu, M. C., Garraffo, R., Guilhaumou, R., Solas, C.

Publikováno v: Antiviral Research
Antiviral Research, 2020, 181, pp.104866. ⟨10.1016/j.antiviral.2020.104866⟩

International audience; In the context of the COVID-19 pandemic, several drugs have been repurposed as potential candidates for the treatment of COVID-19 infection. While preliminary choices were essentially based on in vitro potency, clinical transl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1398::e3b195ad34607edfd1d91c99e40e9c4e
https://hal.science/hal-03147202

La pharmacogénétique moléculaire hospitalière en France : données actuelles et perspectives

Autor: Allorge, D., Beaune, P.-H., Becquemont, L., Bessard, G., Bezieau, S., Boisdron-Celle, M., Boyer, J.-C., Broly, F., Dhaneens, C.-M., Fonrose, X., Gagnieu, M.-C., Gamelin, E., Gozé, C., Jacqz-Aigrain, E., Loric, S., Loriot, M.-A., Marquet, P., Morel, A., Namour, B., Paintaud, G., Peoc’h, K., Picard, N., Watier, H., Verstuyft, C.

Publikováno v: In Annales Pharmaceutiques Francaises 2007 65(6):371-381

Subcutaneous suppressive antibiotic therapy for bone and joint infections: safety and outcome in a cohort of 10 patients

Autor: Lippman, J., Braun, E., Servien, E., Batailler, C., Gaillard, R., Gunst, S., Roger, J., Fiquet, C., Viste, A., Chaudier, P., Besse, J. L., Louboutin, L., Gaudin, G., Ledru, T., Van Haecke, A., Ode, Q., Mercier, M., Alech-Tournier, F., Martres, S., Trouillet, F., Barrey, C., Jouanneau, E., Jacquesson, T., Gerenton, B., Mojallal, A., Boucher, F., Shipkov, H., Ceruse, P., Fuchsmann, C., Gleizal, A., Aubrun, F., Dziadzko, M., Macabeo, C., Beraut, L., Dupieux, C., Kolenda, C., JOSSE, J., Gustave, C. A., Craighero, F., Boussel, L., Pialat, J. B., Morelec, I., Tod, M., Gagnieu, M. C., Mabrut, E., Lyon Bone Joint Infection, Study, Goutelle, S., Lustig, S., Daoud, F., Fessy, M. H., Cohen, S., Laurent, F., Chidiac, C., Valour, F., Ferry, T., Perpoint, T., Miailhes, P., Ader, F., Becker, A., Roux, S., Triffault-Fillit, C., Conrad, A., Perry, M., Pouderoux, C.

Publikováno v: Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2019, 74 (7), pp.2060--2064. ⟨10.1093/jac/dkz104⟩
Journal of Antimicrobial Chemotherapy, 2019, 74 (7), pp.2060--2064. ⟨10.1093/jac/dkz104⟩

Background Optimal treatment of prosthetic joint infection and chronic osteomyelitis consists of surgical removal of biofilm-embedded bacteria, followed by a 6–12 week course of antimicrobial therapy. However, when optimal surgery is not feasible,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d3d5e5e208b16b8fbee76cd690c1016
https://hal.archives-ouvertes.fr/hal-02466240

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.